Send to

Choose Destination
See comment in PubMed Commons below
J Org Chem. 2013 Aug 16;78(16):8054-64. doi: 10.1021/jo4012514. Epub 2013 Aug 2.

Rational design, synthesis, and characterization of deep blue phosphorescent Ir(III) complexes containing (4'-substituted-2'-pyridyl)-1,2,4-triazole ancillary ligands.

Author information

  • 1Department of Chemistry, Pusan National University, Busan 609-735, Korea.

Erratum in

  • J Org Chem. 2013 Dec 6;78(23):12281.


On the basis of the results of frontier orbital considerations, 4-substituted-2'-pyridyltriazoles were designed to serve as ancillary ligands in 2-phenylpyridine main ligand containing heteroleptic iridium(III) complexes that display deep blue phosphorescence emission. The iridium(III) complexes, Ir1-Ir7, prepared using the new ancillary ligands, were found to display structured, highly quantum efficient (Φp = 0.20-0.42) phosphorescence with emission maxima in the blue to deep blue 448-456 nm at room temperature. In accord with predictions based on frontier orbital considerations, the complexes were observed to have emission properties that are dependent on the electronic nature of substituents at the C-4 position of the pyridine moiety of the ancillary ligand. Importantly, placement of an electron-donating methyl group at C-4' of the pyridine ring of the 5-(pyridine-2'-yl)-3-trifluoromethyl-1,2,4-triazole ancillary ligand leads to an iridium(III) complex that displays a deep blue phosphorescence emission maximum at 448 nm in both the liquid and film states at room temperature. Finally, an OLED device, constructed using an Ir-complex containing the optimized ancillary ligand as the dopant, was found to emit deep blue color with a CIE of 0.15, 0.18, which is close to the perfect goal of 0.15, 0.15.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for American Chemical Society
    Loading ...
    Write to the Help Desk